Vice President, Head of Neuropsychiatry Clinical Development

Company: 6084-Janssen Research & Development Legal Enti
Location: Titusville
Posted on: April 1, 2026

Job Description:

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com . As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Discovery & Pre-Clinical/Clinical Development Job Sub Function: Clinical Development & Research – MD Job Category: People Leader All Job Posting Locations: Cambridge, Massachusetts, United States of America, Raritan, New Jersey, United States of America, San Diego, California, United States of America, Spring House, Pennsylvania, United States of America, Titusville, New Jersey, United States of America Job Description: Johnson & Johnson, is recruiting for a Vice President, Head of Neuropsychiatry Clinical? Development to be based at one of our sites in Titusville, NJ; Raritan, NJ; Cambridge, MA; Spring House, PA; La Jolla, CA. Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Neuroscience team tackles the world’s toughest brain health challenges including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, epilepsy, major depressive disorder, bipolar disorder, schizophrenia, and autism. This patient-focused team helps address some of the most complex diseases of our time. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine The VP, Head of Neuropsychiatry (NP) Clinical Development is accountable for strategic leadership and oversight of all Neuropsychiatry related clinical programs and clinical development activities from Phase 2b through the end of Phase 3, certain phase 4 studies may also be in scope. RESPONSIBILITIES: Core member of the Disease Area Leadership Team (DALT) and the Neuroscience Development Leadership Team The VP NP has responsibility for the NP development strategy in alignment with Disease Area Strategies, and for assuring an integrated, efficient, effective and timely implementation of that strategy. The VP NP ensures that CDTs develop thoughtful, integrated asset development strategies and appropriately capture these in the Asset Development Plan document. Helping teams identify and addresses the key issues, alternative strategies considered, and key stages of development (with associated GO/NO GO decision points and criteria). The VP NP working with the Compound Development Team Leader (CDTL) assures that the issues and concerns of the functional partners are addressed so that the clinical strategy and the implementation of that strategy is comprehensive, effective, and highly integrated. The VP NP has ultimate responsibility and accountability within NP for protocol design and for final protocols, clinical study reports, and clinical components of regulatory packages/submissions. He or she may delegate some of these responsibilities, as appropriate. The VP NP represents the clinical development group to the rest of the franchise, and to the units of JRD and other Janssen R&D companies. The VP NP is responsible for decisions regarding external presentation of clinical research data, including timing and appropriateness of content. In this role, the VP NP will work with the CDTL, DAS lead and with functional partners from global medical affairs, health care compliance, legal regulatory, and other relevant groups. The VP NP is responsible for final approval of each compound’s risk language working closely with the Clinical Leader, the CDTL, and the Global Medical Safety (GMS) group representative The VP NP is responsible for assuring appropriate clinical input and direction for programs, and is expected to provide review and input, from the clinical development perspective, for all programs going for Development Forum discussion and DALT and NSRB (Neuroscience Review Board) approval. The VP NP is accountable for providing leadership to the clinical research staff within NP, assuring the high quality of work produced, and that the staff is provided with timely, detailed, and constructive feedback, and that the staff is progressing in their professional development. The VP NP has financial accountability for the teams for which he/she is responsible. The DH is accountable for business plans (BPs) and executing according to the business plans. The VP NP is responsible for building and maintaining a top-quality clinical research unit, staffed with industry-leading clinical research staff. EDUCATION AND EXPERIENCE: MD or equivalent, MD/PhD a plus, Board Certification in Psychiatry or international equivalent is preferred At least 15 years of professional experience with a minimum of 10 years in pharmaceutical R&D Experience of phase late phase study design, execution and interpretation including regulatory filings Experience of a leadership role in a multifunctional R&D organization Needs to be a strategic thinker Experience in a leadership role within a global multi-functional R&D matrix organization; strong track record of producing results in a matrix-based environment. Strong oral and written communication skills Fluent in written and spoken English Experience and knowledge of Good Clinical Practices and regulatory requirements for the conduct of clinical trials and for the appropriate contributions to regulatory filings Thorough knowledge of the drug development process is required. Familiarity with pharmaceutical portfolio risk management is required. Knowledge of global regulatory authority procedures and interactions required. Must have a high degree of organizational awareness and understanding of change management. Must have strong people management skills, including demonstrated people development. Must be a strong collaborator, including influencing without authority and conflict resolution skills. Must have strong problem-solving skills for developing creative solutions and meeting project objectives. Demonstrated ability for strategic thinking and contingency planning is required. Must have strong oral/written communication and interpersonal skills, allowing effective interactions with all levels of the organization. Must have solid analytical skills for integrating and interpreting interdisciplinary project information. The anticipated base pay range for this position is $258,000 to $476,100. The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation’s performance over a calendar/performance year. Bonuses are awarded at the Company’s discretion on an individual basis. Employees and/or eligible dependents may be eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance. Employees may be eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k)). This position is eligible to participate in the Company’s long-term incentive program. Employees are eligible for the following time off benefits: Vacation – up to 120 hours per calendar year Sick time - up to 40 hours per calendar year; for employees who reside in the State of Washington – up to 56 hours per calendar year Holiday pay, including Floating Holidays – up to 13 days per calendar year of Work, Personal and Family Time - up to 40 hours per calendar year Additional information can be found via the following link: https://www.careers.jnj.com/employee-benefits The compensation and benefits information set forth in this posting applies to candidates hired in the United States. Candidates hired outside the United States will be eligible for compensation and benefits in accordance with their local market. Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act. Johnson & Johnson is committed to providing an interview process that is inclusive of our applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please contact us via https://www.jnj.com/contact-us/careers or contact AskGS to be directed to your accommodation resource. LI-Hybrid Required Skills: Preferred Skills: Clinical Development, Clinical Research and Regulations

Keywords: 6084-Janssen Research & Development Legal Enti, Fairfield , Vice President, Head of Neuropsychiatry Clinical Development, Healthcare , Titusville, Connecticut